Insulin degludec: all 127 studies that test it
Page 2 of 2. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 DiabetesCompletedNCT01455142Phase 1
- Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese SubjectsCompletedNCT01437592Phase 1
- Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy SubjectsCompletedNCT01319240Phase 1
- Comparison of Two Identical NN1250 Formulations in Healthy VolunteersCompletedNCT01193387Phase 1
- A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 DiabetesCompletedNCT01174303Phase 1
- Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT01173926Phase 1
- A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 DiabetesCompletedNCT01154881Phase 1
- A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy SubjectsCompletedNCT01151072Phase 1
- A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 DiabetesCompletedNCT01138488Phase 1
- A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 DiabetesCompletedNCT01135927Phase 1
- A Trial Investigating the Effect of NN5401 in Subjects With Type 2 DiabetesCompletedNCT01134224Phase 1
- A Comparison Between Two Formulations of NN5401 in Healthy SubjectsCompletedNCT01125553Phase 1
- A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 DiabetesCompletedNCT01114542Phase 1
- Comparison of Two NN1250 Formulations in Subjects With Type 1 DiabetesCompletedNCT01076634Phase 1
- Effect of NN5401 in Japanese Subjects With Type 1 DiabetesCompletedNCT01051102Phase 1
- The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic OriginCompletedNCT01043510Phase 1
- A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 DiabetesCompletedNCT01030926Phase 1
- A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal FunctionCompletedNCT01006057Phase 1
- Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 DiabeticsCompletedNCT01002768Phase 1
- Investigation of the Response Relationship of NN5401 in Type 1 DiabeticsCompletedNCT00993096Phase 1
- Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 DiabeticsCompletedNCT00992537Phase 1
- Safety and Tolerability of NN9068 in Healthy Male VolunteersCompletedNCT00983021Phase 1
- A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver FunctionCompletedNCT00976326Phase 1
- Comparison of Two NN1250 Formulations in Healthy VolunteersCompletedNCT00966368Phase 1
- A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 DiabeticsCompletedNCT00964964Phase 1
- A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 DiabetesCompletedNCT00964418Phase 1
- A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 DiabetesCompletedNCT00961324Phase 1